Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Nucleic Acids Res ; 35(3): 801-11, 2007.
Article in English | MEDLINE | ID: mdl-17202157

ABSTRACT

Active promoters generally contain histone H3/H4 hyperacetylation and tri-methylation at H3 lysine 4, whereas repressed promoters are associated with DNA methylation. Here we show that the repressed erythroid-specific carbonic anhydrase II (CAII) promoter has active histone modifications localized around the transcription start, while high levels of CpG methylation are present directly upstream from these active marks. Despite the presence of active histone modifications, the repressed promoter requires hormone-induced activation for efficient preinitiation complex assembly. Transient and positional changes in histone H3/H4 acetylation and local changes in nucleosome density are evident during activation, but the bipartite epigenetic code is stably maintained. Our results suggest that active histone modifications may prevent spreading of CpG methylation towards the promoter and show that repressive DNA methylation immediately adjacent to a promoter does not necessarily repress transcription.


Subject(s)
CpG Islands , DNA Methylation , Gene Silencing , Histones/metabolism , Promoter Regions, Genetic , Acetylation , Animals , Carbonic Anhydrase II/genetics , Carbonic Anhydrase II/metabolism , Cell Line , Erythroid Precursor Cells/metabolism , Histones/chemistry , Nucleosomes/metabolism , Transcription Factors/metabolism , Transcription, Genetic/drug effects , Triiodothyronine/pharmacology
2.
EMBO J ; 21(6): 1389-97, 2002 Mar 15.
Article in English | MEDLINE | ID: mdl-11889044

ABSTRACT

To assess the mechanisms of repression of the erythroid-specific carbonic anhydrase II (CAII) locus we used chromatin immunoprecipitation and show that an NCoR-histone deacetylase (HDAC)3 complex is recruited by the nuclear receptor v-ErbA to the intronic HS2 enhancer turning it into a potent silencer. Furthermore we demonstrate that efficient CAII silencing requires binding of a MeCP2-targeted HDAC-containing corepressor complex to the hypermethylated CpG-island at the promoter. Activation of transcription by either AZAdC or thyroid hormone results in loss of one of the two corepressor complexes. Thyroid hormone further replaces the enhancer-bound NCoR-corepressor complex by the TRAP220 coactivator. Treatment with the HDAC inhibitor trichostatin A (TSA) causes activation of CAII transcription and histone H3 and H4 hyperacetylation at the enhancer, apparently without affecting binding of the two corepressor complexes. Unexpectedly, histone H3 and H4 at the fully repressed promoter are already hyperacetylated despite the close apposition of the MeCP2-targeted HDAC complex. Acetylation of histone H4, but not H3, at the promoter is moderately increased following TSA treatment. Our data suggest that the hyperacetylated but repressed CAII promoter is (partially) remodeled and primed for activation in v-ErbA-transformed cells.


Subject(s)
Carbonic Anhydrase II/genetics , Chromosomal Proteins, Non-Histone , CpG Islands , DNA-Binding Proteins/metabolism , Gene Expression Regulation, Enzymologic , Histone Deacetylases/metabolism , Nuclear Proteins/metabolism , Repressor Proteins/metabolism , Transcriptional Activation , Acetylation , Cell Line, Transformed , Humans , Methyl-CpG-Binding Protein 2 , Nuclear Receptor Co-Repressor 1 , Oncogene Proteins v-erbA/genetics , Oncogene Proteins v-erbA/metabolism , Promoter Regions, Genetic , Protein Binding , Triiodothyronine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL